Radiomics Analysis for Clinical Decision Support in ۱۷۷Lu-DOTATATE Therapy of Metastatic Neuroendocrine Tumors using CT Images

سال انتشار: 1403
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 160

فایل این مقاله در 12 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_JBPE-14-5_001

تاریخ نمایه سازی: 16 مهر 1403

چکیده مقاله:

Background: Radiomics is the computation of quantitative image features extracted from medical imaging modalities to help clinical decision support systems, which could ultimately meliorate personalized management based on individual characteristics. Objective: This study aimed to create a predictive model of response to peptide receptor radionuclide therapy (PRRT) using radiomics computed tomography (CT) images to decrease the dose for patients if they are not a candidate for treatment. Material and Methods: In the current retrospective study, ۳۴ patients with neuroendocrine tumors whose disease is clinically confirmed participated. Effective factors in the treatment were selected by eXtreme gradient boosting (XGBoost) and minimum redundancy maximum relevance (mRMR). Classifiers of decision trees (DT), random forest (RF), and K-nearest neighbors (KNN) with selected quantitative and clinical features were used for modeling. A confusion matrix was used to evaluate the performance of the model. Results: Out of ۸۶۶ quantitative and clinical features, nine features with the XGBoost method and ten features with the mRMR pattern were selected that had the most relevance in predicting response to treatment. Selected features of the XGBoost method in integration with the RF classifier provided the highest accuracy (accuracy: ۸۹%), and features selected by the mRMR method in combination with the RF classifier showed satisfactory performance (accuracy: ۷۴%).  Conclusion: This exploratory analysis shows that radiomic features with high accuracy can effectively predict response to personalize treatment.

نویسندگان

Baharak Behmanesh

Department of Nuclear Physics Faculty of Science, Urmia University, Oroumieh, Iran

Akbar Abdi-Saray

Department of Nuclear Physics Faculty of Science, Urmia University, Oroumieh, Iran

Mohammad Reza Deevband

Department of Biomedical Engineering and Medical Physics, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Mahasti Amoui

Department of Nuclear Medicine, Shohada-e Tajrish Hospital, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Hamid Reza Haghighatkhah

Department of Radiology and Medical Imaging Center, Shohada-e Tajrish Hospital, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • Mirvis E, Toumpanakis C, Mandair D, Gnanasegaran G, Caplin M, ...
  • Mittra ES. Neuroendocrine Tumor Therapy: ۱۷۷Lu-DOTATATE. AJR Am J Roentgenol. ...
  • Weilin M, Xu H, Yang L, Wenqi C, Huanyu W, ...
  • Chan DL, Singh S. Current Chemotherapy Use in Neuroendocrine Tumors. ...
  • Chicheportiche A, Grozinsky-Glasberg S, Gross DJ, Krausz Y, et al. ...
  • Dash A, Pillai MR, Knapp FF Jr. Production of (۱۷۷)Lu ...
  • Smith-Palmer J, Leeuwenkamp OR, Virk J, Reed N. Lutetium oxodotreotide ...
  • Abou Jokh Casas E, Pubul Núñez V, Anido-Herranz U, et ...
  • Levart D, Kalogianni E, Corcoran B, Mulholland N, Vivian G. ...
  • Dromain C, Sundin A, Najran P, Vidal Trueba H, Dioguardi ...
  • Liang W, Yang P, Huang R, Xu L, Wang J, ...
  • Zhao Z, Bian Y, Jiang H, Fang X, Li J, ...
  • Horvat N, Bates DDB, Petkovska I. Novel imaging techniques of ...
  • Fave X, Zhang L, Yang J, Mackin D, Balter P, ...
  • Meng Y, Sun J, Qu N, Zhang G, Yu T, ...
  • Biomarkers Definitions Working Group. Biomarkers and surrogate endpoints: preferred definitions ...
  • Strosberg J, El-Haddad G, Wolin E, Hendifar A, Yao J, ...
  • Van Griethuysen JJM, Fedorov A, Parmar C, Hosny A, et ...
  • Larue RT, Defraene G, De Ruysscher D, Lambin P, van ...
  • Rizzo S, Botta F, Raimondi S, Origgi D, Fanciullo C, ...
  • Wang J, Xu J, Zhao C, Peng Y, Wang H. ...
  • Berrendero JR, Cuevas A, Torrecilla JL. The mRMR variable selection ...
  • Islam MR, Kamal ARM, Sultana N, Islam R, Moni MA, ...
  • Blanco-Justicia A, Domingo-Ferrer J. Machine learning explainability through comprehensible decision ...
  • Forghani R, Savadjiev P, Chatterjee A, Muthukrishnan N, Reinhold C, ...
  • Paul A, Mukherjee DP, Das P, Gangopadhyay A, Chintha AR, ...
  • Coroller TP, Grossmann P, Hou Y, Rios Velazquez E, Leijenaar ...
  • Susmaga R. Confusion matrix visualization. Intelligent information processing and web ...
  • Grimaldi S, Terroir M, Caramella C. Advances in oncological treatment: ...
  • Green S, Weiss GR. Southwest Oncology Group standard response criteria, ...
  • Crombé A, Kind M, Ray-Coquard I, Isambert N, Chevreau C, ...
  • Ligero M, Garcia-Ruiz A, Viaplana C, Villacampa G, Raciti MV, ...
  • Vergote I, Rustin GJS, Eisenhauer EA, Kristensen GB, Pujade-Lauraine E, ...
  • Nishino M. Tumor Response Assessment for Precision Cancer Therapy: Response ...
  • Huynh E, Coroller TP, Narayan V, Agrawal V, Hou Y, ...
  • Longadge R, Dongre S. Class Imbalance Problem in Data Mining ...
  • Bethanney Janney J, Roslin SE, Kumar SK. ۶ - Analysis ...
  • Zhou Y, He L, Huang Y, Chen S, Wu P, ...
  • Bian Y, Jiang H, Ma C, Wang L, Zheng J, ...
  • Sala E, Mema E, Himoto Y, Veeraraghavan H, Brenton JD, ...
  • Hunter LA, Krafft S, Stingo F, Choi H, Martel MK, ...
  • نمایش کامل مراجع